WebSep 17, 2024 · In June 30, 2024, Guangdong Zhongqiang Pharmaceutical reported a total common equity of CNY 80.6 million, total assets of CNY 80.6 million, negative EBIT of CNY 0.5 million and net loss of CNY 0.5 million. The deal is subject to the board approval of Guangdong Zhongsheng Pharmaceutical which was approved. WebSolliciteer naar de functie van OTC推广专员(深圳) bij Guangdong Zhongsheng Pharmaceutical Co., Ltd. Voornaam. Achternaam. E-mailadres. Wachtwoord (meer dan …
Zsp1603, a class I innovative drug of Zhongsheng pharmaceutical ...
WebNov 1, 2024 · Guangdong Zhongsheng Pharmaceutical Company Overview Update this profile Founded 1979 Status Public Employees 1,626 Stock Symbol 002317 Investments 5 Share Price $3.25 (As of Friday Closing) General Information Description Guangdong Zhongsheng Pharmaceutical Co Ltd is engaged in the pharmaceutical business. penny black reservations
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)
WebMar 10, 2024 · Guangdong Zhongsheng Pharmaceutical Co., Ltd. About the company Rewards Became profitable this year Risk Analysis Earnings have declined by 32% per year over past 5 years Highly volatile share price over the past 3 months Unstable dividend track record See All Risk Checks My Notes Capture your thoughts, links and company … WebSource: Sina Pharmaceutical News 2024-10-11 today (October 11) Guangdong Zhongsheng Pharmaceutical Co., Ltd (hereinafter referred to as "the company" or "Zhongsheng pharmaceutical") announced that it has recently received the approval document for clinical trials of zsp1603, a class I innovative drug, and the notice of … WebGuangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) Shenzhen - Shenzhen Delayed Price. Currency in CNY Follow 21.00 -0.19 (-0.90%) At close: 03:04PM CST Company Insights Conversations... to bury in latin